Varenicline dihydrochloride
Cat. No.: IBDI-431912
Varenicline (CP 526555) dihydrochloride is a potent partial agonist for α4β2 nicotinic acetylcholine receptor (nAChR) with an EC50 value of 2.3 μM. Varenicline dihydrochloride is a full agonist for α3β4 and α7 nAChRs with EC50 values of 55 μM and 18 μM, respectively. Varenicline dihydrochloride is a nicotinic ligand based on the structure of cytosine, and has the potential for smoking cessation treatment.
Product Details
| Target |
nAChR |
| Molecular Weight |
284.18 |
| Synonyms |
CP 526555 dihydrochloride |
| SMILES |
[H]Cl.[H]Cl.C1(C2)CNCC2C3=CC4=NC=CN=C4C=C13 |
Storage & Handling
| Shipping |
Room temperature in continental US. May vary elsewhere. |
| Storage |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| Regulatory Status |
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. |
! For research use only, not intended for any clinical use.
